Clinical Trials Browser

Phase 2 × Neoplasms × Alemtuzumab × Clear all

NCT00895739 2013-08-12

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

Phase 2 Unknown

Classical hematology

Anemia, Aplastic, Neoplasms